Host factors in breast cancer recurrence

Acid suppressing therapy as a risk factor for Candida esophagitis.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2015

Osteoporosis due to androgen deprivation therapy in men with prostate cancer.

Urology·2001

Hypogonadism following prostate-bed radiation therapy for prostate carcinoma.

Cancer·2001

Progressive osteoporosis during androgen deprivation therapy for prostate cancer.

The Journal of urology·1999

A worse prognosis for men with testicular atrophy at therapeutic orchiectomy for prostate carcinoma.

Cancer·1998

Testicular atrophy in therapeutic orchiectomy specimens from men with prostate carcinoma: association with prior prostate bed radiation and older age.

Cancer·1998

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Clinical characteristics and prognostic factors associated with recurrence in periocular basal cell carcinoma in a Taiwanese population.

Japanese journal of ophthalmology·2026

Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trials.

Breast cancer research and treatment·2026

DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression.

Molecular biology reports·2026

Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center.

World journal of urology·2026

Integrated Phytochemical, Computational and In Vitro Evaluation of the Oocysticidal Activity of Pleurotus ostreatus Extract Against Cryptosporidium parvum.

Cell biochemistry and biophysics·2026

Related Experiment Videos

Host factors in breast cancer recurrence

Related Concept Videos

Acid suppressing therapy as a risk factor for Candida esophagitis.

Osteoporosis due to androgen deprivation therapy in men with prostate cancer.

Hypogonadism following prostate-bed radiation therapy for prostate carcinoma.

Progressive osteoporosis during androgen deprivation therapy for prostate cancer.

A worse prognosis for men with testicular atrophy at therapeutic orchiectomy for prostate carcinoma.

Testicular atrophy in therapeutic orchiectomy specimens from men with prostate carcinoma: association with prior prostate bed radiation and older age.

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

Clinical characteristics and prognostic factors associated with recurrence in periocular basal cell carcinoma in a Taiwanese population.

Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era.

The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trials.

DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression.

Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center.

Integrated Phytochemical, Computational and In Vitro Evaluation of the Oocysticidal Activity of Pleurotus ostreatus Extract Against Cryptosporidium parvum.

Related Experiment Videos

Host factors in breast cancer recurrence

Related Concept Videos

Related Articles